$100M for Tmunity's Cancer Gene Therapy From China, U.S. Investors

Tuesday, January 23, 2018

Funding for Tmunity Therapeutics, a for-profit company that develops T-cell-based personal cancer treatments led by Carl June of the Perelman School of Medicine, is highlighted.

Article Source: Philadelphia Inquirer